This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1953 Jun;12(2):88-94.

doi: 10.1136/ard.12.2.88.

Observations on the treatment of rheumatoid arthritis with butazolidin

J P CURRIE, R A BROWN, G WILL

PMID: 13058275
PMCID: PMC1030462
DOI: 10.1136/ard.12.2.88

Observations on the treatment of rheumatoid arthritis with butazolidin

J P CURRIE et al. Ann Rheum Dis. 1953 Jun.

. 1953 Jun;12(2):88-94.

doi: 10.1136/ard.12.2.88.

Authors

J P CURRIE, R A BROWN, G WILL

PMID: 13058275
PMCID: PMC1030462
DOI: 10.1136/ard.12.2.88

No abstract available

PubMed Disclaimer

Similar articles

Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis.
STEPHENS CA Jr, YEOMAN EE, HOLBROOK WP, HILL DF, GOODIN WL. STEPHENS CA Jr, et al. J Am Med Assoc. 1952 Nov 15;150(11):1084-6. doi: 10.1001/jama.1952.03680110024007. J Am Med Assoc. 1952. PMID: 12990356 No abstract available.
Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone.
BRODIE BB, LOWMAN EW, BURNS JJ, LEE PR, CHENKIN T, GOLDMAN A, WEINER M, STEELE JM. BRODIE BB, et al. Am J Med. 1954 Feb;16(2):181-90. doi: 10.1016/0002-9343(54)90333-2. Am J Med. 1954. PMID: 13124349 No abstract available.
Observations on the use of butazolidin in arthritis.
DAVIES HR, BARTER RW, GEE A, HIRSON C. DAVIES HR, et al. Br Med J. 1952 Dec 27;2(4799):1392-4. Br Med J. 1952. PMID: 12997794 Free PMC article. No abstract available.
[Rheumatoid arthritis: treatment in 1972].
Lussier A, Myhal D. Lussier A, et al. Union Med Can. 1972 Jul;101(7):1346-51. Union Med Can. 1972. PMID: 4339505 Review. French. No abstract available.
Optimum therapeutic program in seropositive nodular rheumatoid arthritis.
Smyth CJ. Smyth CJ. Med Clin North Am. 1968 May;52(3):687-98. Med Clin North Am. 1968. PMID: 4874560 Review. No abstract available.

See all similar articles

Cited by

Antirheumatic drugs: clinical pharmacology and therapeutic use.
Craig GL, Buchanan WW. Craig GL, et al. Drugs. 1980 Dec;20(6):453-84. doi: 10.2165/00003495-198020060-00002. Drugs. 1980. PMID: 7009134 Review.
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design.
Tanaka M, Szatmári I, Vécsei L. Tanaka M, et al. Pharmaceuticals (Basel). 2025 Apr 22;18(5):607. doi: 10.3390/ph18050607. Pharmaceuticals (Basel). 2025. PMID: 40430428 Free PMC article. Review.
Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis.
Brooks PM, Walker JJ, Dick WC. Brooks PM, et al. Br J Clin Pharmacol. 1975 Oct;2(5):437-42. doi: 10.1111/j.1365-2125.1975.tb00553.x. Br J Clin Pharmacol. 1975. PMID: 786356 Free PMC article. Clinical Trial.
Lost in Translation? Cortisone and the Treatment of Rheumatoid Arthritis in Britain, 1950-1960. [corrected].
Worboys M, Toon E. Worboys M, et al. Hist Philos Life Sci. 2019 Nov 7;41(4):54. doi: 10.1007/s40656-019-0269-7. Hist Philos Life Sci. 2019. PMID: 31701313 Free PMC article. Review.

References

1. J Am Med Assoc. 1952 Nov 15;150(11):1084-6 - PubMed
1. Int Rec Med Gen Pract Clin. 1952 Sep;165(9):467-72 - PubMed
1. Br Med J. 1952 Dec 27;2(4799):1392-4 - PubMed
1. J Am Med Assoc. 1952 Jun 21;149(8):729-34 - PubMed
1. Ann Rheum Dis. 1952 Dec;11(4):308-9 - PubMed

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources